Transaction · 0001193125-26-220718

Windsor James Brian

WINDSOR JAMES BRIAN, SR, reported an open-market or private purchase at Rein Therapeutics, Inc. involving 25000.000000 shares for an estimated $25000.00. Reported holdings after the transaction were 27046.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PSR
RNTXRein Therapeutics, Inc.
Trade date
Apr 30, 2026
Filing date
May 13, 2026
View on SEC Insider profile
Disclosed value$25.0kShares × reported price
Shares traded25.0k$1.00 per share
Holdings after27.0kDirect
% of reported position traded1,221.9%This security and ownership context
How reported position traded is calculated

Shares purchased ÷ (holdings after − shares purchased). Estimated position before: 2,046 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 13 calendar days after the transaction date.

RNTX price since this filing

Daily closing prices, with the filing date and available return windows
RNTX · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001193125-26-220718
Common stock , $0.001 par value
Transaction date
Apr 30, 2026
Filed May 13, 2026, 12:47 PM · 13d delay
Shares
25,000 sh
$1.00 per share
Estimated value
$25.0k
Computed from shares × price
Holdings after
27,046 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Delayed Filing Director Buy Direct Ownership Large Holdings Increase
Filing-only score

+26 points

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

How this score is calculated
  • open_market_purchase+12 points

    transaction_code = P

    Code P is a discretionary open-market purchase.
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • director_buy+6 points

    is_director = true

    Director open-market purchase.
  • large_holdings_increase+8 points

    large-holdings-increase signal matched

    Reported acquired shares meet the configured percentage of post-transaction holdings.
  • delayed_filing-6 points

    reporting_delay_days = 13

    Filing delay exceeds the configured threshold.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

See Remarks

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Shares purchased in Issuer's April 30, 2026 follow-on public offering.

  2. F2

    This option was granted on May 8, 2026. The 25% of the shares underlying the option are scheduled to vest on May 8, 2027 and thereafter in equal monthly installments through May 8, 2031.

Original filing · 0001193125-26-220718
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

RNTX